RUBY JADE IBARRA: Open Payments
NPI 1720853286 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $390
Food & beverage: $390
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $147 |
| Exact Sciences Corporation | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 1 | $99 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: Wegovy, The Cologuard Plus Collection Kit, BREZTRI, TRELEGY ELLIPTA, GVOKE HYPOPEN, Rybelsus.
Industry payments across MD — which companies pay providers there.
